Literature DB >> 16081823

Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.

Michelle N Wykes1, Yong-Hong Zhou, Xue Q Liu, Michael F Good.   

Abstract

Malaria is a serious cause of morbidity and mortality for people living in endemic areas, but unlike many other infections, individuals exposed to the parasite do not rapidly become resistant to subsequent infections. High titers of Ab against the 19-kDa C-terminal fragment of the merozoite surface protein-1 can mediate complete protection in model systems; however, previous studies had not determined whether this vaccine generated long-term protection. In this study, we report that functional memory cells generated by merozoite surface protein-1, per se, do not offer any protection. This is because the parasite induces deletion of vaccine-specific memory B cells as well as long-lived plasma cells including those specific for bystander immune responses. Our study demonstrates a novel mechanism by which Plasmodium ablates immunological memory of vaccines, which would leave the host immuno-compromised.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081823     DOI: 10.4049/jimmunol.175.4.2510

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Why haven't we made an efficacious vaccine for malaria?

Authors:  Michelle N Wykes
Journal:  EMBO Rep       Date:  2013-07-12       Impact factor: 8.807

2.  Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice.

Authors:  Gregory S Noland; Debabani Roy Chowdhury; Joseph F Urban; Fidel Zavala; Nirbhay Kumar
Journal:  Vaccine       Date:  2010-02-25       Impact factor: 3.641

3.  Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival.

Authors:  Xue Q Liu; Katryn J Stacey; Joshua M Horne-Debets; Jasmyn A Cridland; Katja Fischer; David Narum; Fabienne Mackay; Susan K Pierce; Michelle N Wykes
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

4.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

5.  Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice.

Authors:  Shigeto Yoshida; Hitomi Araki; Takashi Yokomine
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

6.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

7.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

8.  Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.

Authors:  Jiraprapa Wipasa; Chaisuree Suphavilai; Lucy C Okell; Jackie Cook; Patrick H Corran; Kanitta Thaikla; Witaya Liewsaree; Eleanor M Riley; Julius Clemence R Hafalla
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

9.  Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.

Authors:  Shigeto Yoshida; Hiroshi Nagumo; Takashi Yokomine; Hitomi Araki; Ayaka Suzuki; Hiroyuki Matsuoka
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Authors:  Simon J Draper; Anna L Goodman; Sumi Biswas; Emily K Forbes; Anne C Moore; Sarah C Gilbert; Adrian V S Hill
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.